SEC Form 4 · accession 0001171843-16-013102
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph I Bower
Director
Period of report
Nov 7, 2016
Accepted (ET)
Nov 9, 2016 · 7:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 7, 2016 | M | 1,540 | $12.36 | A | 38,513 | D | |
| Common StockF2 | Nov 7, 2016 | F | 431 | $44.26 | D | 38,082 | D | |
| Common StockF3 | Nov 9, 2016 | S | 500 | $43.40 | D | 37,582 | D | |
| Common StockF3 | Nov 9, 2016 | S | 40 | $43.31 | D | 37,542 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF1 | $12.36 | Nov 7, 2016 | M | 1,540 | D | — | — | Common Stock | 1,540 | 0 | D |
Explanation of responses
- F1Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016.
- F2Reflects 431 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on November 7, 2016.
- F3Reflects an aggregate of 540 shares of common stock sold to satisfy tax obligations related to the exercise of the above listed SARs award by the Reporting Person on November 9, 2016.